ELDN – eledon pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Eledon Pharmaceuticals, Inc.'s (NASDAQ:ELDN) market cap dropped US$48m last week; individual investors who hold 57% were hit as were institutions [Yahoo! Finance]
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results [Yahoo! Finance]
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results
Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
Form 8-K Eledon Pharmaceuticals, For: Dec 16
Form 4 Eledon Pharmaceuticals, For: Nov 21 Filed by: Perrin Steven
Form 4 Eledon Pharmaceuticals, For: Nov 21 Filed by: Little Paul Sean
Form 4 Eledon Pharmaceuticals, For: Nov 21 Filed by: Smith Bryan E.
Form 4 Eledon Pharmaceuticals, For: Nov 21 Filed by: Gros David-Alexandre C
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.